Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.

被引：0
|
作者：
Herrera, Alex Francisco
Tracy, Samuel
Sehn, Laurie Helen
Jardin, Fabrice
Lenz, Georg
Trneny, Marek
Salles, Gilles A.
Flowers, Christopher
Tilly, Herve
Sharman, Jeff Porter
Friedberg, Jonathan W.
Balasubramanian, Sandhya
Raghavan, Vibha
Hirata, Jamie H.
Lee, Calvin
Jiang, Yanwen
Morschhauser, Franck
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] Ctr Henri Becquerel, Rouen, France
[3] Univ Rouen, Rouen, France
[4] Univ Hosp Munster, Munster, Germany
[5] Charles Univ Prague, Gen Hosp, Prague, Czech Republic
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[9] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[10] Hoffmann Roche Ltd, Mississauga, ON, Canada
[11] Univ Lille, Ctr Hosp Univ, Lille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7523
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma
    Rajamouli, Srichandhana
    McLaughlin, Eric
    Hanel, Walter
    Bond, David A.
    Sawalha, Yazeed
    Voorhees, Timothy J.
    Alinari, Lapo
    Sehgal, Lalit
    Maddocks, Kami J.
    Christian, Beth
    Jones, Daniel
    Epperla, Narendranath
    BLOOD, 2022, 140 : 6659 - 6660
  • [22] Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non-Asian patients with previously untreated diffuse large B-cell lymphoma in POLARIX
    Liao, Michael Z.
    Deng, Rong
    Gibiansky, Leonid
    Lu, Tong
    Agarwal, Priya
    Dere, Randall
    Lee, Calvin
    Hirata, Jamie
    Herbaux, Charles
    Salles, Gilles
    Li, Chunze
    Miles, Dale
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2744 - 2755
  • [23] Prognostic nomogram for overall survival in previously untreated patients with diffuse large B-cell lymphoma
    Han, Y.
    Qin, Y.
    Liu, P.
    Yang, J.
    He, X.
    Zhou, S.
    Gui, L.
    Yang, S.
    Zhang, C.
    Huang, Y.
    Jiang, S.
    Shi, Y.
    Wang, Q.
    Sun, Y.
    Shi, Y-K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] A pilot study of epratuzumab and rituximab in combination with CHOP chemotherapy (ER-CHOP) in previously untreated patients with diffuse large B-cell lymphoma (DLBCL).
    Micallef, INM
    Kahl, BS
    Gayko, U
    Cesano, A
    Ansell, SM
    Colgan, JP
    Geyer, S
    Maurer, MJ
    Inwards, DJ
    White, WL
    Horning, SJ
    Habermann, TM
    BLOOD, 2003, 102 (11) : 643A - 644A
  • [25] Prognostic Value of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma Reply
    Kurtz, David M.
    Scherer, Florian
    Jin, Michael C.
    Soo, Joanne
    Craig, Alexander F. M.
    Esfahani, Mohammad S.
    Chabon, Jacob J.
    Stehr, Henning
    Liu, Chih Long
    Tibshirani, Robert
    Maeda, Lauren S.
    Gupta, Neel K.
    Khodadoust, Michael S.
    Advani, Ranjana H.
    Newman, Aaron M.
    Duehrsen, Ulrich
    Huettmann, Andreas
    Meignan, Michel
    Casasnovas, Olivier
    Westin, Jason R.
    Roschewski, Mark
    Wilson, Wyndham H.
    Gaidano, Gianluca
    Rossi, Davide
    Diehn, Maximilian
    Alizadeh, Ash A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (09) : 755 - +
  • [26] Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
    Cherng, Hua-Jay J.
    Herrera, Alex
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (05) : 659 - 678
  • [27] R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes
    Seymour, John F.
    Pfreundschuh, Michael
    Trneny, Marek
    Sehn, Laurie H.
    Catalano, John
    Csinady, Eva
    Moore, Nicola
    Coiffier, Bertrand
    HAEMATOLOGICA, 2014, 99 (08) : 1343 - 1349
  • [28] Type of tissue biopsy and outcomes in diffuse large B-cell lymphoma (DLBCL).
    Desai, Sanjal
    Mwangi, Raphael
    King, Rebecca L.
    Maurer, Matthew J.
    Cerhan, James Robert
    Feldman, Andew L.
    Habermann, Thomas Matthew
    Mou, Eric
    Farooq, Umar
    Thompson, Carrie A.
    Wang, Yucai
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Management Strategies and Outcomes for Very Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Chihara, Dai
    Ahmed, Mohamed Amin
    Oki, Yasuhiro
    Westin, Jason R.
    Hagemeister, Fredrick B.
    Romaguera, Jorge E.
    Fanale, Michelle A.
    Lee, Hun Ju
    Turturro, Francesco
    Samaniego, Felipe
    Neelapu, Sattva S.
    Rodriguez, Alma
    Fowler, Nathan
    Wang, Michael
    Fayad, Luis E.
    Davis, Richard Eric
    Nastoupil, Loretta
    BLOOD, 2015, 126 (23)
  • [30] Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era
    Al-Juhaishi, Taha
    Al-Kindi, Sadeer G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 146 - 149
12345